Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suis

Sophie J Smither1, Stuart D Perkins, Carwyn Davies

  • 1Defence Science and Technology Laboratory, Porton Down, Salisbury, Wiltshire, United Kingdom. sjsmither@dstl.gov.uk

Insights

Developing effective vaccines against Brucella, a bioterrorism threat, is crucial. Mouse models for aerosolized Brucella melitensis and Brucella suis infections were created to test vaccine efficacy, using the Rev.1 vaccine strain.

Area of Science:

  • Microbiology and immunology
  • Vaccine development
  • Infectious disease modeling

Background:

  • Brucella species pose a significant bioterrorism risk.
  • Effective vaccines are needed for protection against Brucella infections.
  • Existing countermeasures may be insufficient.

Purpose of the Study:

  • To establish and validate mouse models for evaluating Brucella vaccines.
  • To assess the utility of aerosolized infection models for vaccine testing.
  • To identify promising vaccine candidates against Brucella.

Main Methods:

  • Development of mouse models for aerosolized Brucella melitensis and Brucella suis infection.
  • Utilizing live vaccine strain Rev.1 of B. melitensis for model validation.
  • Infection challenge studies in established mouse models.

Main Results:

  • Successfully developed functional mouse models for Brucella infection.
  • Demonstrated the utility of these models for vaccine evaluation.
  • Validated the models using a known live Brucella vaccine strain.

Conclusions:

  • The developed mouse models are effective tools for Brucella vaccine assessment.
  • These models will aid in the identification of novel vaccines against Brucella.
  • Advancing vaccine strategies against bioterrorism agents like Brucella is feasible.

Related Concept Videos